ventricular tachycardia, ventricular fibrillation, chronic heart failure
Conditions
Interventions
cases with frailty / sarcopenia
cases without frailty / sarcopenia
Sponsors
Hamamatasu University School of Medicine, Division of Cardiology, Internal Medicine III
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. ICD or CRT are going to be implanted due to ventricular tachyarrhythmia and chronic heart failure 2. The cases who give written informed consent
Exclusion criteria
Exclusion criteria: 1. the cases in whom principal investigator or co-investigators judge unsuitable to include.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| composite endpoint of heart failure hospitalization and death | — |
Secondary
| Measure | Time frame |
|---|---|
| procedural related complications appropriate ICD therapy including anti-tachycardia pacing and cardio-version heart failure hospitalization all cause death cardiovascular death | — |
Countries
Japan
Contacts
Public ContactYoshihisa Naruse
Hamamatasu University School of Medicine Division of Cardiology, Internal Medicine III
Outcome results
None listed